Category: Drug Prices & Regulations
Saturday Links
- Sales of dog strollers last year outpaced those of baby strollers for the first time in South Korea – home to the world’s lowest birthrate.(WSJ)
- How the New York Times stoked Covid alarmism.
- “Overall, benchmark premiums increased 75 percent between 2014 and 2024—more than 60 percent higher than the premium growth in employer plans during this time.”
- Does Joe Stiglitz deserve the blame for thousands of murders and poverty and misery in Venezuela?
- Taxpayers lose to fraud, fraud and more fraud.
- Means-tested social-welfare spending totaled $1.6 trillion in 2023, absorbing 72.6% of unobligated general revenue minus Social Security, Medicare and interest payments.
Friday Links
- Conventional wisdom holds that it takes 17 years from medical innovation to adoption in the real-world.
- Aaron Caroll on the market for prescription drugs.
- Once applicable to fewer than 500 covered entities, the 340B Program now consists of nearly 13,000 entities, including hospitals, federally qualified health centers (FQHCs), and nearly 30,000 contract pharmacies.
- Doctors are using problematic race-based algorithms to guide care every day.
- Census Bureau: real median family income is lower today than it was in 2019.
WSJ: Senators Want to Crack Down on Social Media Influencers Touting Drugs and Bogus Health Remedies
Have you noticed that drug commercials for debilitating diseases often end with healthy people going about their lives after taking the drug. Then, off camera a fast-talking man or woman rushes through a list of hideous potential side effects. The reason for the fast-talking narrator is because the list of major side effects and contraindications are required by law. Now a Senate Committee is up in arms that influencers on TikTok, YouTube and Instagram, are touting weight-loss drugs for money but aren’t disclosing side effects.